Transphorm Q1 Adj $(0.08) Beats $(0.11) Estimate, Sales $5.88M Miss $5.92M Estimate
Portfolio Pulse from Benzinga Newsdesk
Transphorm (NASDAQ:TGAN) reported Q1 losses of $(0.08) per share, beating the analyst consensus estimate of $(0.11) by 27.27%. However, the company's quarterly sales of $5.88 million missed the analyst consensus estimate of $5.92 million by 0.63%. This represents a 14.10% increase over sales of $5.16 million the same period last year.
August 14, 2023 | 8:16 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Transphorm's Q1 results were mixed with earnings beating estimates but sales missing. This could lead to a mixed reaction in the market.
Transphorm's Q1 results were mixed, with earnings beating estimates but sales missing. This could lead to uncertainty among investors, potentially causing volatility in the stock's price in the short term.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100